Helen of Troy Limited (NASDAQ:HELE) Stock Has Consensus Target Price of $27.50

Shares of Helen of Troy Limited (NASDAQ:HELE) have received an average recommendation of “Moderate Buy” from the five research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and two have given a strong buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $27.50.

Several analysts recently commented on HELE shares. Canaccord Genuity Group raised their price objective on shares of Helen of Troy from $25.00 to $26.00 and gave the company a “hold” rating in a research note on Tuesday, October 6th. Wall Street Zen raised Helen of Troy from a “hold” rating to a “strong-buy” rating in a research note on Sunday, July 12th. Weiss Ratings cut Helen of Troy from a “sell (d)” rating to a “sell (d-)” rating in a report on Tuesday, July 21st. Zacks Research raised Helen of Troy from a “hold” rating to a “strong-buy” rating in a research report on Tuesday. Finally, UBS Group raised their price target on Helen of Troy from $28.00 to $29.00 and gave the stock a “neutral” rating in a research report on Friday, October 9th.

Institutional Investors Weigh In On Helen of Troy

Large investors have recently added to or reduced their stakes in the company. Paradigm Capital Management Inc. NY grew its position in shares of Helen of Troy by 64.3% in the 1st quarter. Paradigm Capital Management Inc. NY now owns 927,100 shares of the company’s stock worth $13,369,000 after acquiring an additional 362,900 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Helen of Troy in the 2nd quarter valued at approximately $2,768,000. Wellington Management Group LLP raised its position in shares of Helen of Troy by 12.8% during the 2nd quarter. Wellington Management Group LLP now owns 824,238 shares of the company’s stock valued at $23,961,000 after acquiring an additional 93,350 shares in the last quarter. Hsbc Holdings PLC acquired a new stake in shares of Helen of Troy during the 1st quarter valued at approximately $1,936,000. Finally, Renaissance Technologies LLC acquired a new stake in shares of Helen of Troy during the 1st quarter valued at approximately $571,000.

Helen of Troy Stock Down 1.8%

Helen of Troy stock opened at $28.99 on Monday. Helen of Troy has a 1-year low of $13.85 and a 1-year high of $31.98. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.65 and a quick ratio of 0.75. The stock has a market cap of $678.08 million, a PE ratio of -6.65 and a beta of 1.34. The stock’s fifty day moving average is $28.15 and its two-hundred day moving average is $25.92.

Helen of Troy (NASDAQ:HELE) last posted its earnings results on Thursday, October 8th. The company reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.29. The business had revenue of $440.93 million for the quarter, compared to analysts’ expectations of $442.33 million. Helen of Troy had a positive return on equity of 7.73% and a negative net margin of 5.43%. The business’s revenue was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.59 earnings per share. Helen of Troy has set its FY 2027 guidance at 3.600-4.150 EPS. On average, sell-side analysts expect that Helen of Troy will post 2.96 EPS for the current fiscal year.

About Helen of Troy

Helen of Troy Limited is a global consumer products company that develops, markets and distributes branded products across the home and outdoor, beauty, and health and wellness categories. Its portfolio includes household and organization products, drinkware and outdoor equipment, personal-care appliances, hair-care products, and consumer health products.

The company’s principal brands include OXO, Hydro Flask, Osprey, Drybar and Hot Tools. Helen of Troy also markets certain health and wellness products under licensed brands, including Vicks, Braun and Honeywell, as well as beauty products under selected licensed and owned brands.